Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-11-3
pubmed:abstractText
The importance of alpha-2-glycoprotein 1, zinc (AZGP1) in lung adenocarcinoma (AD) remains largely unknown. Analysis of serum autoantibodies to tumor antigens combined with gene expression profiling of primary tumors may provide insight into the mechanisms underlying lung carcinogenesis and identify new AD biomarkers.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AZGP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies, http://linkedlifedata.com/resource/pubmed/chemical/Azacitidine, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Histone Acetyltransferases, http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylases, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/histone acetyltransferase type B..., http://linkedlifedata.com/resource/pubmed/chemical/trichostatin A
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1556-1380
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1236-44
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18978557-Acetylation, pubmed-meshheading:18978557-Adenocarcinoma, pubmed-meshheading:18978557-Adult, pubmed-meshheading:18978557-Aged, pubmed-meshheading:18978557-Aged, 80 and over, pubmed-meshheading:18978557-Autoantibodies, pubmed-meshheading:18978557-Azacitidine, pubmed-meshheading:18978557-Carrier Proteins, pubmed-meshheading:18978557-Case-Control Studies, pubmed-meshheading:18978557-Enzyme Inhibitors, pubmed-meshheading:18978557-Female, pubmed-meshheading:18978557-Gene Expression Profiling, pubmed-meshheading:18978557-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18978557-Glycoproteins, pubmed-meshheading:18978557-Histone Acetyltransferases, pubmed-meshheading:18978557-Histone Deacetylase Inhibitors, pubmed-meshheading:18978557-Histone Deacetylases, pubmed-meshheading:18978557-Humans, pubmed-meshheading:18978557-Hydroxamic Acids, pubmed-meshheading:18978557-Immunoenzyme Techniques, pubmed-meshheading:18978557-Lung Neoplasms, pubmed-meshheading:18978557-Male, pubmed-meshheading:18978557-Middle Aged, pubmed-meshheading:18978557-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:18978557-RNA, Messenger, pubmed-meshheading:18978557-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18978557-Survival Rate, pubmed-meshheading:18978557-Tumor Cells, Cultured, pubmed-meshheading:18978557-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
pubmed:affiliation
Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, N.I.H., Extramural